Law Offices of Howard G. Smith Encourages Pinterest, Inc. (PINS) Shareholders To Inquire About Securities Fraud Class Action Law Offices of Howard G. Smith Encourages Pinterest, Inc. (PINS) Shareholders To Inquire About Securities Fraud Class Action Share BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Pinterest, Inc. ("Pinterest†or the "Company†) (NYSE: PINS) securities between February 7, 2025 and Fe ...

SECURITIES CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ramaco Investors of the Securities Class Action Deadline Tonight March 31, 2026 Mar 31, 2026 9:27 AM Eastern Daylight Time SECURITIES CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ramaco Investors of the Securities Class Action Deadline Tonight March 31, 2026 Share Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) WilsonEncourages Investors Who Suffered In Ramaco To Contact Him Directly To Discuss Their Option ...

Core Viewpoint - Halper Sadeh LLC is investigating whether Centessa Pharmaceuticals plc is obtaining a fair price for its shareholders in the proposed sale to Eli Lilly and Company for $38.00 in cash per share plus a contingent value right worth up to $9.00 based on certain milestones [3]. Group 1: Investigation Details - The investigation focuses on whether Centessa and its board violated federal securities laws and/or breached fiduciary duties by failing to secure the best possible price for shareholders, conduct a fair sales process, and disclose all material information necessary for shareholders to evaluate the transaction [5]. - The proposed transaction may include terms that could limit superior competing offers, potentially disadvantaging ordinary shareholders [1]. Group 2: Shareholder Rights - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options at no cost, with the firm operating on a contingent fee basis [2][4]. - Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders [6].

Core Viewpoint - The Schall Law Firm is investigating ePlus inc. for potential violations of securities laws, focusing on whether the company made false or misleading statements and failed to disclose important information to investors [2]. Group 1: Investigation Details - The investigation is centered on ePlus's Q3 financial results announced on February 5, 2025, which fell short of consensus estimates, attributed to "digestion" in the networking space and select enterprise customers [2]. - Following the announcement of the disappointing financial results, ePlus's shares experienced a significant decline of 13.1% the next day [2]. Group 2: Investor Participation - Shareholders who have suffered losses are encouraged to participate in the investigation and can contact the Schall Law Firm for more information [3].

Core Viewpoint - Vital Farms, Inc. is facing a class action lawsuit for securities fraud due to misleading statements regarding the impact of delays related to its new enterprise resource planning (ERP) system [4]. Group 1: Lawsuit Details - The Schall Law Firm is leading a class action lawsuit against Vital Farms for violations of the Securities Exchange Act of 1934 [1]. - Investors who purchased securities between May 8, 2025, and February 26, 2026, are encouraged to participate in the lawsuit before the deadline of May 26, 2026 [2]. - The lawsuit claims that Vital Farms made false statements about the risks associated with its ERP system, which ultimately led to missed earnings per share [4]. Group 2: Investor Information - The Schall Law Firm specializes in securities class action lawsuits and is representing investors globally [5]. - Investors who suffered losses due to the misleading statements are invited to contact the firm for a free discussion of their rights [3].

Deadline Soon: China Liberal Education Holdings Limited (CLEUF) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Mar 30, 2026 12:57 PM Eastern Daylight Time Deadline Soon: China Liberal Education Holdings Limited (CLEUF) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Share LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruzreminds investors of the upcoming March 31, 2026 dead ...

Core Viewpoint - Investors in ImmunityBio, Inc. (NASDAQ: IBRX) have the opportunity to lead a securities fraud lawsuit against the company due to alleged violations of the Securities Exchange Act of 1934 [1][4]. Group 1: Lawsuit Details - The Schall Law Firm is reminding investors of a class action lawsuit against ImmunityBio for making false and misleading statements regarding its Anktiva drug [1][4]. - The class period for the lawsuit is defined as January 19, 2026, to March 24, 2026, during which investors who purchased the company's securities may have suffered losses [2][4]. - Investors are encouraged to contact the Schall Law Firm before May 26, 2026, to discuss their rights and potential participation in the lawsuit [2][3]. Group 2: Company Allegations - The complaint alleges that ImmunityBio overstated the capabilities of its Anktiva drug, leading to materially misleading public statements throughout the class period [4]. - The lawsuit claims that when the truth about ImmunityBio's statements was revealed, investors experienced significant damages [4]. Group 3: Legal Representation - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally [5]. - Investors can reach out to the firm for a free discussion regarding their rights and potential involvement in the lawsuit [3][5].

Core Viewpoint - The Schall Law Firm is investigating Vertical Aerospace Ltd. for potential violations of securities laws, particularly focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Group 1: Company Financials and Concerns - Vertical Aerospace filed its annual report for 2025 with the SEC on March 24, 2026, indicating significant financial concerns, including limited cash, recurring operational losses, and a dependency on raising additional capital, which raises doubts about the company's ability to continue as a going concern [2]. - Following the release of this report, shares of Vertical Aerospace fell by nearly 18.2% on the same day, reflecting investor reaction to the disclosed financial uncertainties [2]. Group 2: Legal Actions and Investor Opportunities - The Schall Law Firm is inviting shareholders who have suffered losses to participate in the investigation and discuss their rights [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, indicating a focus on protecting investor interests [3].

Core Viewpoint - Kirby McInerney LLP is investigating potential securities fraud claims against ADMA Biologics, Inc., focusing on possible violations of federal securities laws and unlawful business practices by the company and its senior management [1][2]. Group 1: Investigation Details - The investigation was prompted by a report from Culper Research on March 24, 2026, alleging that ADMA engaged in "Channel Stuffing" and had undisclosed related party distributors, with a reported growth of +20% in 2025 being misleading as the actual growth was only -3% [2]. - The report indicated that two high-level employees from one of ADMA's largest distributors confirmed that ADMA induced the distributor to stock excess ASCENIV by offering rebates and extended payment terms, allowing the company to book revenues that did not reflect actual sales [2]. Group 2: Market Reaction - Following the publication of the report, ADMA's share price fell by $2.26, or approximately 17%, dropping from $13.59 on March 23, 2026, to close at $11.33 on March 24, 2026 [2].

Core Viewpoint - Robbins LLP has announced a class action lawsuit against Vital Farms, Inc. for allegedly misleading investors regarding its business prospects during the period from May 8, 2025, to February 26, 2026 [1][2]. Allegations - The lawsuit claims that Vital Farms made false and misleading statements about the implementation of an enterprise resource planning (ERP) system, which was said to be crucial for operational improvements [2]. - Defendants allegedly did not disclose that the ERP implementation would lead to delays in shipments and production, which could negatively impact the company's business [2]. - The complaint highlights that management was aware of potential issues surrounding the ERP implementation but failed to adequately inform investors [2]. Financial Performance - On February 26, 2026, Vital Farms reported its fiscal year 2025 revenue at $759.44 million, which was below the guidance of $775 million [3]. - The company also reported earnings per share (EPS) of $0.35, missing the market consensus of $0.39 [3]. - Following the release of this information, Vital Farms' stock price fell by $2.68, or 10.8%, closing at $22.11 [3]. Class Action Participation - Shareholders who purchased Vital Farms securities during the specified period may be eligible to participate in the class action lawsuit [4]. - Interested parties can contact Robbins LLP to serve as lead plaintiff or to receive further information [4]. Company Background - Vital Farms is recognized as a leading U.S. brand of pasture-raised eggs and the second-largest U.S. egg brand by retail dollar sales [1].